Journal profile · Medicine, Research & Experimental
Journal of Biomedical Science
ISSN 1021-7770 · eISSN 1423-0127 · BioMed Central · TAIWAN · Bimonthly · Founded 2008
Journal of Biomedical Science: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 14.41; diamond open access (no APC); no APC; median 139 days to acceptance (93 articles, last 24 months); community-reported acceptance: about 41.66%; 107 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Biomedical Science is published by BioMed Central and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are HIV Research and Treatment, Neuroscience and Neuropharmacology Research and Immune Cell Function and Interaction, together about 18.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Biomedical Science is an open access, peer-reviewed journal that encompasses all fundamental and molecular aspects of basic medical sciences, with an emphasis on the molecular studies of biomedical problems and molecular mechanisms. The journal is supported by the National Science and Technology Council (NSTC), Taiwan, who covers the cost of publication on behalf of the authors on acceptance of their article. Topics of interest include, but are not limited to: anatomic pathology biochemistry genetics immunology microbiology and virology molecular, cellular and cancer biology neurosciences pharmacology physiology Journal of Biomedical Science aims to provide an international forum for encouraging interdisciplinary discussions and contributing to the advancement of medicine, benefiting readers and authors by accelerating the dissemination of research information and providing maximum access to scholarly communication.
From the journal's Aims & Scope
Research area (LetPub): Medicine, Research & Experimental
Editor-in-chief Wen-Chang ChangPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named United States 36, Taiwan, China 12, Japan 6, Hong Kong, China 2, France 2 (64 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- HIV Research and TreatmentImmunology and Microbiology7.4%
- Neuroscience and Neuropharmacology ResearchNeuroscience6.3%
- Immune Cell Function and InteractionImmunology and Microbiology4.7%
- Cardiac electrophysiology and arrhythmiasMedicine4.5%
- Ion channel regulation and functionBiochemistry, Genetics and Molecular Biology4.5%
- Immunotherapy and Immune ResponsesImmunology and Microbiology4.5%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology4.3%
- Nitric Oxide and Endothelin EffectsMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Medicine, Research & Experimental | Zone 1 |
| Minor | Cell Biology | Zone 2 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Cell Biology | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cell Biology | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCAB AbstractsPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 14.41LetPub ·
- Impact factor (publisher) 2025
- 14.5Publisher website ·
- 5-year impact factor (publisher) 2025
- 13.2Publisher website ·
- CiteScore 2026-06
- 21.4LetPub ·
- SJR 2026-06
- 3.6LetPub ·
- SNIP 2026-06
- 2.68LetPub ·
- h-index
- 71LetPub ·
- h-index
- 153OpenAlex ·
- i10-index
- 2,282OpenAlex ·
- 2-year mean citedness
- 14.98OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 101LetPub ·
- Downloads per year (publisher) 2025
- 2,700,000Publisher website ·
Articles by year OpenAlex count · 3,765 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 91 | 91 | 125 |
| 2025 | 107 | 107 | 1,692 |
| 2024 | 105 | 105 | 2,723 |
| 2023 | 96 | 96 | 4,600 |
| 2022 | 109 | 109 | 5,801 |
| 2021 | 126 | 126 | 4,672 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
139 daysMedian, submission to acceptance · P25–P75 97 days – 181 days
- Acceptance to online
- median 25 days (93 articles)
- Submission to online
- median 169 days
- Sample
- 93 articles with submission and acceptance dates (210 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 41.66%LetPub ·
- Submission to first decision
- 25 daysPublisher website ·
- Submission to publication (journal-reported)
- about 14 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY, CC0 | |
| OpenAlex | USD 0 | — | — | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted2
- research articleFormatting guidelines for specific article types can be found below. Research article ReviewLength not stated
- reviewFormatting guidelines for specific article types can be found below. Research article ReviewLength not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, License & copyright, Open access, Peer review
- Authorship
Submission by author only Model summary
Please note that a manuscript can only be submitted by an author of the manuscript and may not be submitted by a third party.
Source ↗Publisher website ·- Data availability Formatting the 'Availability of data and materials' section of your manuscript
CC0 data policy Model summary
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
CC BY (Creative Commons Attribution 4.0 International licence) Model summary
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Journal of Biomedical Science articles are published open access under a CC BY (Creative Commons Attribution…
Source ↗Publisher website ·- Open access Benefits of open access
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Reviewer suggestions allowed Model summary
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BioMed Central
- Country or region
- TAIWAN
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2008
- ISSN
- 1021-7770
- Electronic ISSN
- 1423-0127
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Biomedical Science
What CAS zone is Journal of Biomedical Science in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Biomedical Science is in Zone 1 of Medicine, and in Zone 1 of the minor category Medicine, Research & Experimental / Cell Biology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Biomedical Science?
The latest impact factor listed by LetPub is 14.41; CiteScore 21.4, h-index 153.
How long does peer review take at Journal of Biomedical Science?
Based on the dates recorded on 93 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 139 days (interquartile range 97–181 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 41.66%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal of Biomedical Science based?
Of the 64 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (36), Taiwan, China (12) and Japan (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Biomedical Science?
According to LetPub and DOAJ records, Journal of Biomedical Science is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, Embase, CAS and CAB Abstracts; that list has not been checked against each database.
Is Journal of Biomedical Science open access, and what is the APC?
Journal of Biomedical Science is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .